ArticleBJUI compass2026
Lower trust in artificial intelligence than physicians coexists with high willingness to engage in artificial intelligence-assisted prostate cancer management among active surveillance patients.
Article in BJUI compass, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to examine the sentiment for artificial intelligence (AI) among prostate cancer (PCa) patients on active surveillance (AS) and to evaluate how that sentiment relates to patient willingness to engage with AI. Materials and Methods: We conducted a 23-question online survey (November-December 2025) distributed through an AS platform. Analyses were restricted to 110 respondents with PCa on AS. Outcomes included trust ratings (10-point Likert scale) for physicians versus AI, responses to hypothetical AI management recommendations and perceived concerns and facilitators of trust. Statistical analyses included the Wilcoxon signed-rank tests, the McNemar tests and Fisher's exact tests. Results: Median trust in urologists (8 [IQR 7-9]) exceeded that for AI (6 [IQR 5-7]), with smaller differences for radiologists and pathologists compared with diagnostic AI (all Conclusions: Among AS patients, lower trust in AI compared to physicians coexists with a high optimism for AI and willingness to incorporate AI recommendations into decision-making. This discordance suggests that behavioural adoption of AI-assisted care may precede full patient confidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.